GlassScriptPhysician profile
Emily A Japp
NPI 1104272723
$926.73
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $23.80 · 2022: $323 · 2023: $580.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $580.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $580.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $333.36 | 2021-2023 | Ozempic, Rybelsus |
| Lilly USA, LLC | $148.81 | 2022-2023 | Mounjaro, Retevmo, Trulicity |
| Astrazeneca Pharmaceuticals LP | $80.94 | 2022-2023 | Farxiga |
| Xeris Pharmaceuticals, INC. | $57.16 | 2022-2023 | Recorlev |
| Rhythm Pharmaceuticals, INC. | $40.88 | 2022-2023 | Imcivree |
| Alexion Pharmaceuticals, INC. | $39.27 | 2022-2023 | Strensiq |
| Averitas Pharma INC. | $38.95 | 2023 | Qutenza |
| Amryt Pharma Holdings LTD | $33.71 | 2023 | Mycapssa |
| Horizon Therapeutics Plc | $24.65 | 2023 | Tepezza |
| Ascensia Diabetes Care US INC. | $23.70 | 2023 | |
| Abbott Laboratories | $22.85 | 2023 | Freestyle Libre 3 |
| Radius Health, INC. | $22.42 | 2023 | Tymlos |
| Tandem Diabetes Care, INC. | $17.00 | 2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Bayer Healthcare Pharmaceuticals INC. | $16.08 | 2023 | |
| Recordati_rare_diseases_inc. | $14.03 | 2023 | Isturisa, Signifor Lar |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $12.92 | 2023 | Korlym |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Japp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.